あなたのがんサバイバー経験を社会に活かしませんか？－ペイシェント・アドボカシーと患者・市民参画

あなたのがんサバイバー経験を社会に活かしませんか？－ペイシェント・アドボカシーと患者・市民参画

by Eguichi Hidetoshi (Osaka University)

Humanities, Social Sciences & Thought Medicine & Health MBMedicineMBPHealth systems and services
🎙 Eguichi Hidetoshi (Osaka University) 👥 5K 📅 May 11, 2026 ⏱ 29 min 👁 533 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

patient advocacyPPIcancer survivorpeer supporthealthcare policy

Summary

The video is a lecture by Dr. Hidetoshi Eguchi, a professor at Osaka University, on the topic of patient advocacy and patient and public involvement (PPI) in cancer care. He begins by defining patient advocacy as supporting and representing patients’ rights, wishes, and best interests, and explains that it can be performed by professionals, peer supporters, or family members. He introduces the concept of peer support, where individuals with similar experiences help each other, and highlights its importance in cancer care. Dr. Eguchi then discusses the evolution of patient advocacy into PPI, where patients and citizens actively participate in research, guideline development, and healthcare policy. He provides examples from the Japanese Society of Medical Oncology, including the PAL program, which trains patient advocates, and the recent introduction of citizen membership. The lecture also covers the role of the PMDA in drug approval and its engagement with PPI. The video includes a Q&A session where panelists discuss challenges in the healthcare system, the importance of patient voices in policy, and the role of cancer navigators. Overall, the video emphasizes the value of incorporating patient experiences to improve cancer care and policy.

190 words

Critical Evaluation

Value of the Information & Strength of the Argument

The video provides valuable information on patient advocacy and PPI, clearly explaining concepts and their practical applications. The argumentation is solid, based on the speaker’s expertise and examples from the Japanese Society of Medical Oncology. The discussion of the PAL program and the inclusion of patient representatives in guideline development strengthens the credibility. The Q&A session adds practical insights, such as how to participate in such programs and the role of PMDA. The speaker’s arguments are coherent and well-structured, though they rely primarily on anecdotal evidence and institutional examples rather than empirical data.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, as the speaker is a recognized expert and the content aligns with established practices in patient advocacy. The sources cited include the official website of the Japanese Society of Medical Oncology for the certified navigator program. The title accurately reflects the content, focusing on patient advocacy and PPI. The video does not include any commercial advertising. The discussion is well-referenced to institutional programs, but lacks external citations to peer-reviewed literature.

183 words

Title / Content Match

The title accurately reflects the content, which focuses on patient advocacy and patient-public involvement in cancer care.

Quality & Reliability

8/10

The video features a recognized expert in hepatobiliary surgery and vice president of the Japanese Society of Medical Oncology, providing a clear and structured explanation of patient advocacy and PPI. The content is consistent with established concepts and includes references to official programs. However, it is primarily an expert opinion with limited external citations.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

Concurring Sources

Contribution & Novelties

The video provides a clear and accessible introduction to patient advocacy and PPI in the context of cancer care, emphasizing the importance of incorporating patient experiences into healthcare policy and research. It highlights specific initiatives by the Japanese Society of Medical Oncology, such as the PAL program and citizen membership, which are relatively novel in Japan. The discussion on the role of PMDA in PPI is also informative.

Pour aller plus loin :

  • Patient and Public Involvement in Health and Social Care Research — Official UK guidance on PPI.
  • Patient Advocacy: A Concept Analysis — Academic article on patient advocacy.
  • Peer Support in Cancer Care — NCI resource on peer support.

111 words

Radar Profile

The radar profile shows high scores in quality of information and reliability, reflecting the expert's credibility and structured content. The quantity of information is moderate, and the technical level is accessible, making it suitable for a general audience. The overall balance indicates a trustworthy educational resource.

Reliability 8/10

💬 Sur les 0 commentaires analysés, aucune tendance n'est disponible.